SGLT2 inhibitors: Diabetic kidney disease and beyond.

SGLT2 inhibitors: Diabetic kidney disease and beyond. Am J Physiol Renal Physiol. 2020 Oct 05;: Authors: Staruschenko A, Bhalla V, Rangaswami J PMID: 33017191 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33017191?dopt=Abstract

Source: American Journal of Physiology. Renal Physiology - October 4, 2020 Category: Physiology Authors: Staruschenko A, Bhalla V, Rangaswami J Tags: Am J Physiol Renal Physiol Source Type: research

More News: Diabetes | Endocrinology | Physiology | SGLT2 Inhibitors | Urology & Nephrology